News from us and our partners

Tags

Topics

0 results

News
6 October, 2023
Asceneuron welcomes Barbara Angehrn Pavik as new CEO as it gears up for next phase of growth
News
27 September, 2023
Chroma Medicine appoints Michael Kelly to board of directors
News
27 September, 2023
Sitryx raises additional $39 million to progress development of disease-modifying therapeutics for chronic autoimmune and inflammatory disease
News
26 September, 2023
CorWave announces the appointment of Magalie Durrèche as Chief Financial Officer
News
26 September, 2023
Moon Surgical announces first clinical cases in the U.S. using Maestro System
News
21 September, 2023
Pyrowave launches nanopurification technology for plastic recycling
News
20 September, 2023
Pi-Cardia successfully completes enrollment in pivotal study for ShortCut™
News
19 September, 2023
Moon Surgical announces CE Mark for its commercial Maestro System
News
13 September, 2023
Mironid extends Series A round, raising £35 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney disease
News
12 September, 2023
FDA approves Limflow System in patients with chronic limb-threatening ischemia and no suitable endovascular or surgical revascularization options
News
12 September, 2023
First finished products made with recycled styrene generated through Pyrowave technology
News
12 September, 2023
First patients treated with TISSIUM’s Atraumatic Hernia Repair System
News
12 September, 2023
AAVantgarde appoints Dr. Doug Kerr to the Board of Directors
News
7 September, 2023
Myricx enters into antibody license agreement with Biocytogen
News
7 September, 2023
Moon Surgical's first-in-human trials feature in major surgical publication
News
7 September, 2023
Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys

Asceneuron welcomes Barbara Angehrn Pavik as new CEO as it gears up for next phase of growth

Chroma Medicine appoints Michael Kelly to board of directors

Sitryx raises additional $39 million to progress development of disease-modifying therapeutics for chronic autoimmune and inflammatory disease

CorWave announces the appointment of Magalie Durrèche as Chief Financial Officer

Moon Surgical announces first clinical cases in the U.S. using Maestro System

Pyrowave launches nanopurification technology for plastic recycling

Pi-Cardia successfully completes enrollment in pivotal study for ShortCut™

Moon Surgical announces CE Mark for its commercial Maestro System

Mironid extends Series A round, raising £35 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney disease

FDA approves Limflow System in patients with chronic limb-threatening ischemia and no suitable endovascular or surgical revascularization options

First finished products made with recycled styrene generated through Pyrowave technology

First patients treated with TISSIUM’s Atraumatic Hernia Repair System

AAVantgarde appoints Dr. Doug Kerr to the Board of Directors

Myricx enters into antibody license agreement with Biocytogen

Moon Surgical's first-in-human trials feature in major surgical publication

Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys